Publication: Evaluation of 3-O-methyldopa as a biomarker for aromatic L-amino acid decarboxylase deficiency in 7 Brazilian cases
This research article, published in Molecular Genetics and Metabolism Reports, evaluates and validates 3-O-methyldopa (3-OMD) as a biomarker for aromatic L-amino acid decarboxylase (AADC) deficiency
- Learn about the validation of 3-OMD as a reliable and stable marker for the identification of AADC deficiency, using dried blood spot (DBS) samples of 7 AADC deficiency patients and 35 non-AADC deficiency controls
- Understand the limitations of current diagnostic tests for AADC deficiency
- Recognize the potential utility of 3-OMD quantification performed in DBS’ in newborn screening
Kubaski F, et al. Mol Genet Metab Rep. 2021;27:100744
Thank you!
Already registered?
Register now to access the content on this page
Already registered?
If not, register below
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
MED-ALL-CORP-2200029 | June 2025
COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.